{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-23-122617","form_type":"8-K","ticker":"LQDA","cik":"0001819576","company_name":"Liquidia Corp","filed_at":"2023-12-01T23:59:59+00:00","discovered_at":"2026-05-14T18:03:30.667311+00:00","generated_at":"2026-06-07T19:30:32.452032+00:00","sec_items":["7.01","9.01"],"event_type":"litigation","sentiment":"negative","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Liquidia faces new patent infringement claim over '327 patent added to PH-ILD suit","bullets":["United Therapeutics amended complaint adds U.S. Patent No. 11,826,327, issued Nov 28, 2023.","Patent covers inhaled treprostinil for PH-ILD; YUTREPIA label amendment triggers claim.","Liquidia believes no 30-month stay applies because patent issued after original NDA filing.","Case continues in U.S. District Court for Delaware; Liquidia vows vigorous defense."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-23-122617","json":"https://secwatch.observer/filing/0001104659-23-122617.json","markdown":"https://secwatch.observer/filing/0001104659-23-122617.md","text":"https://secwatch.observer/filing/0001104659-23-122617.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1819576/000110465923122617/0001104659-23-122617-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1819576/000110465923122617/tm2331419d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-07T19:30:32.452032+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}